Unknown PHASE4 INTERVENTIONAL 1-arm NCT04577027

Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo

Safety And Efficacy Of Topical Prostaglandin F2α Analogs In Combination With Fractional CO2 Laser And 308 Excimer Light In Treatment Of Vitiligo

Sponsor: Assiut University

Conditions Excimer Laser Fractional CO2 Laser Vitiligo

Interventions Combination therapy Excimer laser Excimer laser and travoprost Fractional CO2 laser Topical travoprost 0.004% solution fractional CO2 laser and topical travoprost

Updated 5 times since 2020 Last updated: Oct 19, 2020 Started: Jan 1, 2021 Primary completion: Jan 1, 2022 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04577027, this PHASE4 trial focuses on Excimer Laser and Fractional CO2 Laser and remains ongoing. Sponsored by Assiut University, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2022 [monthly]

Not Yet Recruiting PHASE4
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.